Welcome to LookChem.com Sign In|Join Free

CAS

  • or

178872-69-0

Post Buying Request

178872-69-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

178872-69-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 178872-69-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,8,8,7 and 2 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 178872-69:
(8*1)+(7*7)+(6*8)+(5*8)+(4*7)+(3*2)+(2*6)+(1*9)=200
200 % 10 = 0
So 178872-69-0 is a valid CAS Registry Number.

178872-69-0Upstream product

178872-69-0Relevant articles and documents

Synthesis of sialyl Lewis X analogues

Dekany, Gyula,Wright, Karen,Ward, Peter,Toth, Istvan

, p. 383 - 398 (1996)

Sialyl Lewis X (SLex) analogs 2a and 2b were synthesised, where the N-acetyl-D-glucose and the D-galactose units of SLex 1 were replaced with an alkyl and a heteroalkyl spacer. Sulphate ester 6i was also synthesised from alcohol 6b and chlorosulphonic acid. A novel promoter, silver mercaptoethanesulphonate, was used to synthesise α-sialosides 2c, 7b and 7c.

COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF BROMODOMAIN-CONTAINING PROTEINS

-

, (2017/03/21)

The present invention relates to bifunctional compounds, which find utility as modulators of targeted ubiquitination, especially inhibitors of a variety of polypeptides and other proteins which are degraded and/or otherwise inhibited by bifunctional compounds according to the present invention. In particular, the present invention is directed to compounds, which contain on one end a VHL ligand which binds to the ubiquitin ligase and on the other end a moiety which binds a target protein such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of that protein. The present invention exhibits a broad range of pharmacological activities associated with compounds according to the present invention, consistent with the degradation/inhibition of targeted polypeptides.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 178872-69-0